Tag: breast cancer trial
Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial
Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting its primary endpoint, progression-free survival ... Read More